The Korean Journal of Pain

  • 제36권2호
  • /
  • Pages.147-148
  • /
  • 2023
  • /
  • 2005-9159(pISSN)
  • /
  • 2093-0569(eISSN)
대한통증학회 (The Korean Pain Society)
권호 표지
DOI QR코드

DOI QR Code

The analgesic effect of programmed cell death protein-1

  • Jong Yeon Park (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine)
  • 투고 : 2023.03.09
  • 심사 : 2023.03.15
  • 발행 : 2023.04.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Su X, Wang B, Zhou Z, Li Z, Tong S, Chen S, et al. A positive feedback loop of heparanase/syndecan1/nerve growth factor regulates cancer pain progression. Korean J Pain 2023; 36: 60-71. https://doi.org/10.3344/kjp.22277
  2. Zhao J, Roberts A, Wang Z, Savage J, Ji RR. Emerging role of PD-1 in the central nervous system and brain diseases. Neurosci Bull 2021; 37: 1188-202. https://doi.org/10.1007/s12264-021-00683-y
  3. Chen G, Kim YH, Li H, Luo H, Liu DL, Zhang ZJ, et al. PD-L1 inhibits acute and chronic pain by suppressing nociceptive neuron activity via PD-1. Nat Neurosci 2017; 20: 917-26. Erratum in: Nat Neurosci 2019; 22: 503.
  4. Jiang C, Wang Z, Donnelly CR, Wang K, Andriessen AS, Tao X, et al. PD-1 regulates GABAergic neurotransmission and GABA-mediated analgesia and anesthesia. iScience 2020; 23: 101570.
  5. Syn NL, Teng MWL, Mok TSK, Soo RA. De-novo and acquired resistance to immune checkpoint targeting. Lancet Oncol 2017; 18: e731-41. https://doi.org/10.1016/S1470-2045(17)30607-1
  6. Makuku R, Khalili N, Razi S, Keshavarz-Fathi M, Rezaei N. Current and future perspectives of PD-1/PDL-1 blockade in cancer immunotherapy. J Immunol Res 2021; 2021: 6661406.
  7. Zhao S, Li F, Leak RK, Chen J, Hu X. Regulation of neuroinflammation through programed death-1/programed death ligand signaling in neurological disorders. Front Cell Neurosci 2014; 8: 271.
  8. Liu BL, Cao QL, Zhao X, Liu HZ, Zhang YQ. Inhibition of TRPV1 by SHP-1 in nociceptive primary sensory neurons is critical in PD-L1 analgesia. JCI Insight 2020; 5: e137386.
  9. Wang Z, Jiang C, He Q, Matsuda M, Han Q, Wang K, et al. Anti-PD-1 treatment impairs opioid antinociception in rodents and nonhuman primates. Sci Transl Med 2020; 12: eaaw6471.